FDA Inspection 679887 — Collegium Pharmaceutical, Inc

Collegium Pharmaceutical, Inc — FEI 3005150234

The FDA completed an inspection of Collegium Pharmaceutical, Inc on August 31, 2010 in Stoughton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 31, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stoughton, MA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
113421 CFR 211.25(b)Supervisor Training/Education/Experience
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
180921 CFR 211.160(a)Following/documenting laboratory controls
188321 CFR 211.165(a)Testing and release for distribution
191221 CFR 211.166(a)Written program not followed
203121 CFR 211.194(a)Complete test data included in records
430321 CFR 211.67(b)Written procedures fail to include